IRAK1 and myocardial infarction: Because atherosclerotic-induced MI and bacterial-induced cardiac septic shock share common characteristics of myocardial dysfunction, pharmacological inhibition of IRAK1 may reduce cardiac inflammation and provide beneficial effects for patients with heart disease [3].